Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
about
Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literatureCefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndromeThe K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.Effects of age and gender on pharmacokinetics of cefepimePharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment.Treatment of bacterial meningitis: an update.Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.Open trial of cefepime (BMY 28142) for infections in hospitalized patients.Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain.Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats.Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An in Vivo Study With an Experimental Model of Foreign-Body Infection.
P2860
Q28189190-F8D60B41-CD6F-4BE5-AC10-B69164D3C175Q33750327-98796362-09E9-4E07-BCF7-B154AEC85FE2Q35821829-F1511520-11A1-4571-82F1-84A93A810243Q35862379-1DB347E2-0302-42D5-809E-E793D93A80F1Q36758208-342DBC92-A2C4-47FD-B46F-37385F435412Q38044024-F8762104-08EF-4B4F-96A2-455073E0E1E4Q39779559-480EFF76-91C9-4BB0-A6E4-22A9ED180A98Q39815828-3721A0AB-FC76-4684-8B40-64EFA4F7D6ABQ39816064-587F26C9-2511-4BB9-B325-CDDAF08079E0Q39875827-B2D56FA9-ECF5-4231-BCBD-E66C72D757F3Q40165407-0E1D07F4-8581-44F8-A4AD-116DA03D3020Q46611262-79FCA21F-8C35-4213-B100-B3FB6E4F81F9Q54344327-AAFE7C56-0526-41B3-92B4-5842293E5303Q55228263-153BAECD-767A-47D0-AE30-E93A70A5DB53
P2860
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@ast
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@en
type
label
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@ast
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@en
prefLabel
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@ast
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@en
P2860
P356
P1476
Efficacy of BMY-28142 in exper ...... coli and group B streptococci.
@en
P2093
P2860
P356
10.1128/AAC.28.1.51
P407
P577
1985-07-01T00:00:00Z